Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR)

123 filings reported holding AVIR - Atea Pharmaceuticals, Inc. - COMMON STOCK as of Q4 2024.
Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) has 103 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 56.3M shares of 85.4M outstanding shares and own 65.98% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (9.06M shares), BML Capital Management, LLC (7.61M shares), FMR LLC (6.43M shares), TANG CAPITAL MANAGEMENT LLC (4.79M shares), VANGUARD GROUP INC (4.67M shares), EcoR1 Capital, LLC (3.34M shares), Bain Capital Life Sciences Investors, LLC (2.49M shares), GEODE CAPITAL MANAGEMENT, LLC (1.92M shares), STATE STREET CORP (1.79M shares), and RENAISSANCE TECHNOLOGIES LLC (1.22M shares).
This table shows the top 103 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.